Annual revenue:
$58.84M+$14.26M(+32.00%)Summary
- As of today (September 18, 2025), RXRX annual revenue is $58.84 million, with the most recent change of +$14.26 million (+32.00%) on December 31, 2024.
- During the last 3 years, RXRX annual revenue has risen by +$48.66 million (+478.10%).
- RXRX annual revenue is now at all-time high.
Performance
RXRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$19.22M+$4.48M(+30.37%)Summary
- As of today (September 18, 2025), RXRX quarterly revenue is $19.22 million, with the most recent change of +$4.48 million (+30.37%) on June 30, 2025.
- Over the past year, RXRX quarterly revenue has increased by +$4.81 million (+33.34%).
- RXRX quarterly revenue is now -26.30% below its all-time high of $26.08 million, reached on September 30, 2024.
Performance
RXRX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$64.60M+$4.81M(+8.04%)Summary
- As of today (September 18, 2025), RXRX TTM revenue is $64.60 million, with the most recent change of +$4.81 million (+8.04%) on June 30, 2025.
- Over the past year, RXRX TTM revenue has increased by +$14.96 million (+30.14%).
- RXRX TTM revenue is now -0.90% below its all-time high of $65.18 million, reached on September 30, 2024.
Performance
RXRX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RXRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.0% | +33.3% | +30.1% |
| 3 y3 years | +478.1% | +150.5% | +257.4% |
| 5 y5 years | +2437.3% | +10000.0% | +10000.0% |
RXRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +478.1% | -26.3% | +322.9% | -0.9% | +257.4% |
| 5 y | 5-year | at high | +2437.3% | -26.3% | >+9999.0% | -0.9% | >+9999.0% |
| alltime | all time | at high | +2437.3% | -26.3% | >+9999.0% | -0.9% | >+9999.0% |
RXRX Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $19.22M(+30.4%) | $64.60M(+8.0%) |
| Mar 2025 | - | $14.74M(+224.4%) | $59.79M(+1.6%) |
| Dec 2024 | $58.84M(+32.0%) | $4.55M(-82.6%) | $58.84M(-9.7%) |
| Sep 2024 | - | $26.08M(+80.9%) | $65.18M(+31.3%) |
| Jun 2024 | - | $14.42M(+4.5%) | $49.63M(+7.4%) |
| Mar 2024 | - | $13.79M(+26.7%) | $46.23M(+3.7%) |
| Dec 2023 | $44.58M(+11.9%) | $10.89M(+3.4%) | $44.58M(-5.9%) |
| Sep 2023 | - | $10.53M(-4.4%) | $47.36M(-5.3%) |
| Jun 2023 | - | $11.02M(-9.2%) | $49.99M(+7.2%) |
| Mar 2023 | - | $12.13M(-11.3%) | $46.64M(+17.1%) |
| Dec 2022 | $39.84M | $13.68M(+3.9%) | $39.84M(+38.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $13.16M(+71.5%) | $28.70M(+58.8%) |
| Jun 2022 | - | $7.67M(+43.9%) | $18.07M(+39.6%) |
| Mar 2022 | - | $5.33M(+110.5%) | $12.95M(+27.2%) |
| Dec 2021 | $10.18M(+156.9%) | $2.53M(-0.0%) | $10.18M(+33.1%) |
| Sep 2021 | - | $2.53M(-0.6%) | $7.64M(+24.6%) |
| Jun 2021 | - | $2.55M(-0.5%) | $6.14M(+62.6%) |
| Mar 2021 | - | $2.56M(+150.0%) | $3.77M(+196.9%) |
| Dec 2020 | $3.96M(+70.8%) | - | - |
| Sep 2020 | - | $1.02M(+451.1%) | $1.27M(+416.7%) |
| Jun 2020 | - | $186.00K(+210.0%) | $246.00K(+310.0%) |
| Mar 2020 | - | $60.00K | $60.00K |
| Dec 2019 | $2.32M | - | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual revenue?
- What is the all time high annual revenue for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual revenue year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly revenue year-on-year change?
- What is Recursion Pharmaceuticals, Inc. TTM revenue?
- What is the all time high TTM revenue for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. TTM revenue year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual revenue?
The current annual revenue of RXRX is $58.84M
What is the all time high annual revenue for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual revenue is $58.84M
What is Recursion Pharmaceuticals, Inc. annual revenue year-on-year change?
Over the past year, RXRX annual revenue has changed by +$14.26M (+32.00%)
What is Recursion Pharmaceuticals, Inc. quarterly revenue?
The current quarterly revenue of RXRX is $19.22M
What is the all time high quarterly revenue for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly revenue is $26.08M
What is Recursion Pharmaceuticals, Inc. quarterly revenue year-on-year change?
Over the past year, RXRX quarterly revenue has changed by +$4.81M (+33.34%)
What is Recursion Pharmaceuticals, Inc. TTM revenue?
The current TTM revenue of RXRX is $64.60M
What is the all time high TTM revenue for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high TTM revenue is $65.18M
What is Recursion Pharmaceuticals, Inc. TTM revenue year-on-year change?
Over the past year, RXRX TTM revenue has changed by +$14.96M (+30.14%)